Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

Conditions

• High Grade Epithelial Ovarian Cancer
• High Grade Serous Ovarian Cancer
• Primary Peritoneal Carcinoma
• Fallopian Tube Cancer
• Endometrial Cancer
• Non-small Cell Lung Cancer
• Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer (NSCLC)
• Mesothelioma
• Breast Adenocarcinoma
• Triple Negative Breast Cancer
• Hormone Receptor-positive/Her2 Negative Breast Cancer
• Platinum-resistant Ovarian Cancer (PROC)
• Platinum Sensitive Ovarian Cancer (PSOC)
• Primary Refractory Ovarian Cancer
• Uterine Cancer

Interventions

• DRUG: Rina-S
• DRUG: Carboplatin
• DRUG: Bevacizumab
• DRUG: Pembrolizumab

Sponsor

Genmab